Compagnie Lombard Odier SCmA - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 68 filers reported holding OCULAR THERAPEUTIX INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2020$6,000
+100.0%
7000.0%0.00%
Q1 2020$3,0000.0%7000.0%0.00%
Q4 2019$3,000
+50.0%
7000.0%0.00%
Q3 2019$2,000
-33.3%
7000.0%0.00%
Q2 2019$3,0000.0%7000.0%0.00%
Q1 2019$3,0000.0%7000.0%0.00%
Q4 2018$3,000
-40.0%
7000.0%0.00%
Q3 2018$5,0000.0%7000.0%0.00%
Q2 2018$5,0000.0%7000.0%0.00%
Q1 2018$5,000
-16.7%
700
-50.0%
0.00%
Q4 2017$6,000
+50.0%
1,400
+100.0%
0.00%
Q3 2017$4,000
-33.3%
7000.0%0.00%
Q2 2017$6,0000.0%7000.0%0.00%
Q1 2017$6,000
-68.4%
700
-68.2%
0.00%
-100.0%
Q4 2016$19,0000.0%2,200
-18.5%
0.00%0.0%
Q3 2016$19,000
+533.3%
2,700
+285.7%
0.00%
Q2 2016$3,000
-57.1%
7000.0%0.00%
Q1 2016$7,0000.0%7000.0%0.00%
Q4 2015$7,0007000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q2 2018
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,861$116,310,000100.00%
Opaleye Management Inc. 6,510,000$134,758,00017.60%
DELTEC ASSET MANAGEMENT LLC 2,168,573$44,889,0006.87%
Versant Venture Management, LLC 1,465,384$30,333,0003.15%
GREAT POINT PARTNERS LLC 856,162$17,723,0002.88%
Affinity Asset Advisors, LLC 220,000$4,554,0002.41%
Altium Capital Management LP 303,174$6,276,0002.34%
Endurant Capital Management LP 290,465$6,013,0002.17%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 50,396$1,043,0001.17%
Lisanti Capital Growth, LLC 366,040$7,577,0001.05%
View complete list of OCULAR THERAPEUTIX INC shareholders